The Evolving Use of White Bagging in Oncology Webinar - Archive

About Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech, and medical device and diagnostic companies. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit www.kantarhealth.com.

The Evolving Use of White Bagging in Oncology Webinar - Archive

In this webinar, Kantar Health examines the current trend of increased use of “white bagging” in community oncology practices, and the dual drivers of payer encouragement and physician choice. Specialty distributors and GPOs support “buy and bill” as the primary method of distribution of oncology drugs. However, a diverse array of competing specialty pharmacies (SPs) already commanding the majority of the oral market, continue to make headway into physician buy and bill via white bagging with the support of payers.

“White bagging” describes physician-administered drugs that are dispensed by a specialty pharmacy and filled through the pharmacy benefit rather than physician buy and bill.

Watch the Webinar

Panelists:


Ricky Newton
Ricky Newton
Practice Manager
Cancer Specialists of Tidewater
Debbie Warner
Debbie Warner
Vice President, Oncology Commercial Strategies
Kantar Health
Winston Wong, PharmD
Winston Wong, PharmD
President
W-Squared Group

Moderated By:


Don Sharpe
Don Sharpe
President
OBR